Adverse events related to low dose corticosteroids in autoimmune hepatitis

Autor: Brand, F.F. van den, Veen, K.S. van der, Lissenberg-Witte, B.I., Boer, Y.S. de, Hoek, B. van, Drenth, J.P.H., Verdonk, R.C., Vrolijk, J.M., Nieuwkerk, C.M.J. van, Bouma, G., Gerven, N.M. van, Kuijvenhoven, J.P., Schreuder, T.C.M.A., Wouden, E.J. van der, Meyel, J.J.M. van, Baak, L.C., Stadhouders, P.H.G.M., Klemt-Kropp, M., Verhagen, M.A.M.T., Bhalla, A., Ouden, J.W. den, Beuers, U., Erpecum, K.J. van, Buuren, H.R. van, Brouwer, J.T., Dutch Autoimmune Hepatitis Study G

Publikováno v: Alimentary Pharmacology & Therapeutics. Wiley
Alimentary Pharmacology & Therapeutics, 50, 1120-1126
Alimentary Pharmacology & Therapeutics, 50, 10, pp. 1120-1126
Alimentary Pharmacology & Therapeutics, 50(10), 1120-1126. Wiley-Blackwell Publishing Ltd
Alimentary Pharmacology and Therapeutics, 50(10), 1120-1126
van den Brand, F F, van der Veen, K S, Lissenberg-Witte, B I, de Boer, Y S, van Hoek, B, Drenth, J P H, Verdonk, R C, Vrolijk, J M, van Nieuwkerk, C M J, Bouma, G & the Dutch Autoimmune Hepatitis Study Group 2019, ' Adverse events related to low dose corticosteroids in autoimmune hepatitis ', Alimentary Pharmacology and Therapeutics, vol. 50, no. 10, pp. 1120-1126 . https://doi.org/10.1111/apt.15528
Alimentary pharmacology & therapeutics, 50(10), 1120-1126. Wiley-Blackwell
Alimentary Pharmacology & Therapeutics

Contains fulltext : 215386.pdf (Publisher’s version ) (Open Access) BACKGROUND: Autoimmune hepatitis requires long-term therapy, and systemic corticosteroids are the backbone of therapeutic management. Prolonged use of corticosteroids may lead to a

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3163eba8675cb92e580487f40cf77564
https://research.rug.nl/en/publications/0b06aee2-a79e-4059-9bfc-519cb26c3f07

Epidemiology and clinical characteristics of autoimmune hepatitis in the Netherlands

Autor: Gerven, N.M.F. van, Verwer, B.J., Witte, B.I., Erpecum, K.J. van, Buuren, H.R. van, Maijers, I., Visscher, A.P., Verschuren, E.C., Hoek, B. van, Coenraad, M.J., Beuers, U.H.W., Man, R.A. de, Drenth, J.P.H., Ouden, J.W. den, Verdonk, R.C., Koek, G.H., Brouwer, J.T., Guichelaar, M.M.J., Vrolijk, J.M., Mulder, C.J.J., Nieuwkerk, C.M.J. van, Bouma, G., Dutch Autoimmune Hepatitis STUDY

Publikováno v: Scandinavian journal of gastroenterology, 49(10), 1245-1254. Informa Healthcare
Scandinavian Journal of Gastroenterology, 49(10), 1245-1254. Informa Healthcare
Scandinavian Journal of Gastroenterology, 49, 10, pp. 1245-54
Scandinavian Journal of Gastroenterology
Scandinavian Journal of Gastroenterology, 49, 1245-54
van Gerven, N M F, Verwer, B J, Witte, B I, van Erpecum, K J, van Buuren, H R, Maijers, I, Visscher, A P, Verschuren, E C, van Hoek, B, Coenraad, M J, Beuers, U H W, de Man, R A, Drenth, J P H, den Ouden, J W, Verdonk, R C, Koek, G H, Brouwer, J T, Guichelaar, M M J, Vrolijk, J M, Mulder, C J J, van Nieuwkerk, C M J & Bouma, G 2014, ' Epidemiology and clinical characteristics of autoimmune hepatitis in the Netherlands ', Scandinavian Journal of Gastroenterology, vol. 49, no. 10, pp. 1245-1254 . https://doi.org/10.3109/00365521.2014.946083
Scandinavian Journal of Gastroenterology, 49(10), 1245-1254

Item does not contain fulltext Abstract Background and aims. Epidemiological data on autoimmune hepatitis (AIH) are scarce. In this study, we determined the clinical and epidemiological characteristics of AIH patients in the Netherlands (16.7 million

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a65fce3db02f3ed5c1cdfdc07481157d
https://hdl.handle.net/1765/84937

HLA-DRB1*03:01 and HLA-DRB1*04:01 modify the presentation and outcome in autoimmune hepatitis type-1

Autor: Gerven, N.M.F. van, Boer, Y.S. de, Zwiers, A., Verwer, B.J., Drenth, J.P.H., Hoek, B. van, Erpecum, K.J. van, Beuers, U., Buuren, H.R. van, Ouden, J.W. den, Verdonk, R.C., Koek, G.H., Brouwer, J.T., Guichelaar, M.J., Vrolijk, J.M., Coenraad, M.J., Kraal, G., Mulder, C.J.J., Nieuwkerk, C.M.J. van, Bloemena, E., Verspaget, H.W., Kumar, V., Zhernakova, A., Wijmenga, C., Franke, L., Bouma, G., Dutch Autoimmune Hepatitis Study G

Publikováno v: Genes and Immunity, 16, 4, pp. 247-52
Genes and immunity, 16(4), 247-252. Nature Publishing Group
van Gerven, N M F, de Boer, Y S, Zwiers, A, Verwer, B J, Drenth, J P H, van Hoek, B, van Erpecum, K J, Beuers, U, van Buuren, H R, den Ouden, J W, Verdonk, R C, Koek, G H, Brouwer, J T, Guichelaar, M J, Vrolijk, J M, Coenraad, M J, Kraal, G, Mulder, C J J, van Nieuwkerk, C M J, Bloemena, E, Verspaget, H W, Kumar, V, Zhernakova, A, Wijmenga, C, Franke, L & Bouma, G 2015, ' HLA-DRB1*03:01 and HLA-DRB1*04:01 modify the presentation and outcome in autoimmune hepatitis type-1 ', Genes and Immunity, vol. 16, no. 4, pp. 247-252 . https://doi.org/10.1038/gene.2014.82
Genes and Immunity, 16(4), 247-252. Nature Publishing Group
Genes and Immunity, 16, 247-52
GENES AND IMMUNITY, 16(4), 247-252. Nature Publishing Group
Genes and Immunity, 16(4), 247-252

The classical human leukocyte antigen (HLA)-DRB1*03:01 and HLA-DRB1*04:01 alleles are established autoimmune hepatitis (AIH) risk alleles. To study the immune-modifying effect of these alleles, we imputed the genotypes from genome-wide association da

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::18d771b0038901538160f49535c9a00d
https://hdl.handle.net/2066/155390

Genome-Wide Association Study Identifies Variants Associated With Autoimmune Hepatitis Type 1

Autor: Boer, Y.S. de, Gerven, N.M.F. van, Zwiers, A., Verwer, B.J., Hoek, B. van, Erpecum, K.J. van, Beuers, U., Buuren, H.R. van, Drenth, J.P.H., Ouden, J.W. den, Verdonk, R.C., Koek, G.H., Brouwer, J.T., Guichelaar, M.M.J., Vrolijk, J.M., Kraal, G., Mulder, C.J.J., Nieuwkerk, C.M.J. van, Fischer, J., Berg, T., Stickel, F., Sarrazin, C., Schramm, C., Lohse, A.W., Weiler-Normann, C., Lerch, M.M., Nauck, M., Volzke, H., Homuth, G., Bloemena, E., Verspaget, H.W., Kumar, V., Zhernakova, A., Wijmenga, C., Franke, L., Bouma, G., Dutch Autoimmune Hepatitis Study, LifeLines Cohort Study, Study Hlth Pomerania

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od_____10693::e43f23c2c7d0cb594160038dd58502d5
https://hdl.handle.net/1887/117557

[Dutch study on the optimal treatment strategy for patients with a first or second occurrence of gastro-oesophageal variceal bleeding: the TIPS-TRUE trial]

Autor: Buuren, H.R. van, Wils, A., Rauws, E.A., Hoek, B. van, Drenth, J.P.H., Kuipers, E.J., Pattynama, P.M.

Publikováno v: Nederlands Tijdschrift voor Geneeskunde, 152, 11, pp. 643-5
Nederlands Tijdschrift voor Geneeskunde, 152, 643-5

Item does not contain fulltext The main options for secondary prevention of gastrooesophageal variceal bleeding are endoscopic therapy and treatment with propranolol. Creation ofa transjugular intrahepatic portosystemic shunt (TIPS) is currently cons

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::1280b704d3007f6bf8d468998ecbdaf1
https://hdl.handle.net/2066/69338